3 results
The main objective of this study is to investigate whether rTMS treatment will improve clinical outcomes in body dysmorphic disorder, by reducing BDD YBOCS outcomes. Furthermore to improve localization and rTMS treatment in the dorsolateral…
Primary Objective: Our primary objective is to quantify whether 8 weeks of treatment with rTMS and CBT in addition to continued pharmacotherapy will outperform the most optimal treatment as usual step (switching or augmenting antidepressants in…
There is a high degree of diversity in attributed risk on thrombosis in the neurosurgical patient cohort. Due to this diversity, insufficient power of performed studies and lack of careful phenotyping and description of risk factors in previous…